nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—MAOA—attention deficit hyperactivity disorder	0.22	0.271	CbGaD
Minaprine—DRD1—attention deficit hyperactivity disorder	0.2	0.246	CbGaD
Minaprine—SLC6A4—attention deficit hyperactivity disorder	0.142	0.175	CbGaD
Minaprine—DRD2—attention deficit hyperactivity disorder	0.141	0.174	CbGaD
Minaprine—HTR2A—attention deficit hyperactivity disorder	0.109	0.134	CbGaD
Minaprine—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.00764	0.152	CbGeAlD
Minaprine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00498	0.099	CbGeAlD
Minaprine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00265	0.0526	CbGeAlD
Minaprine—Moclobemide—MAOA—attention deficit hyperactivity disorder	0.00243	1	CrCbGaD
Minaprine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00158	0.0315	CbGeAlD
Minaprine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00123	0.0244	CbGeAlD
Minaprine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00117	0.0232	CbGeAlD
Minaprine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00116	0.0231	CbGeAlD
Minaprine—HTR2B—forebrain—attention deficit hyperactivity disorder	0.00116	0.023	CbGeAlD
Minaprine—ACHE—midbrain—attention deficit hyperactivity disorder	0.00114	0.0226	CbGeAlD
Minaprine—DRD1—midbrain—attention deficit hyperactivity disorder	0.00105	0.0208	CbGeAlD
Minaprine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.000982	0.0195	CbGeAlD
Minaprine—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000977	0.0194	CbGeAlD
Minaprine—MAOA—forebrain—attention deficit hyperactivity disorder	0.000946	0.0188	CbGeAlD
Minaprine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000936	0.0186	CbGeAlD
Minaprine—ACHE—cerebellum—attention deficit hyperactivity disorder	0.000882	0.0175	CbGeAlD
Minaprine—DRD1—nervous system—attention deficit hyperactivity disorder	0.00086	0.0171	CbGeAlD
Minaprine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000828	0.0164	CbGeAlD
Minaprine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000812	0.0161	CbGeAlD
Minaprine—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.0008	0.0159	CbGeAlD
Minaprine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.00077	0.0153	CbGeAlD
Minaprine—ACHE—brain—attention deficit hyperactivity disorder	0.000716	0.0142	CbGeAlD
Minaprine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000668	0.0133	CbGeAlD
Minaprine—DRD1—brain—attention deficit hyperactivity disorder	0.000657	0.0131	CbGeAlD
Minaprine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000643	0.0128	CbGeAlD
Minaprine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000633	0.0126	CbGeAlD
Minaprine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000631	0.0125	CbGeAlD
Minaprine—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000627	0.0125	CbGeAlD
Minaprine—MAOA—midbrain—attention deficit hyperactivity disorder	0.000625	0.0124	CbGeAlD
Minaprine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000618	0.0123	CbGeAlD
Minaprine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000617	0.0123	CbGeAlD
Minaprine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.00061	0.0121	CbGeAlD
Minaprine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000607	0.0121	CbGeAlD
Minaprine—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000604	0.012	CbGeAlD
Minaprine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000562	0.0112	CbGeAlD
Minaprine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000522	0.0104	CbGeAlD
Minaprine—MAOA—nervous system—attention deficit hyperactivity disorder	0.000514	0.0102	CbGeAlD
Minaprine—HTR2C—brain—attention deficit hyperactivity disorder	0.00051	0.0101	CbGeAlD
Minaprine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000508	0.0101	CbGeAlD
Minaprine—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000494	0.00982	CbGeAlD
Minaprine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000489	0.00971	CbGeAlD
Minaprine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000484	0.00961	CbGeAlD
Minaprine—MAOA—cerebellum—attention deficit hyperactivity disorder	0.000483	0.0096	CbGeAlD
Minaprine—CHRM1—brain—attention deficit hyperactivity disorder	0.000482	0.00958	CbGeAlD
Minaprine—HTR2B—brain—attention deficit hyperactivity disorder	0.00048	0.00953	CbGeAlD
Minaprine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000478	0.00949	CbGeAlD
Minaprine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000408	0.00809	CbGeAlD
Minaprine—MAOA—brain—attention deficit hyperactivity disorder	0.000393	0.0078	CbGeAlD
Minaprine—DRD2—brain—attention deficit hyperactivity disorder	0.000388	0.00771	CbGeAlD
Minaprine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000335	0.00665	CbGeAlD
Minaprine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000323	0.00641	CbGeAlD
Minaprine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000315	0.00626	CbGeAlD
Minaprine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000305	0.00606	CbGeAlD
Minaprine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000294	0.00584	CbGeAlD
Minaprine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000287	0.0057	CbGeAlD
Minaprine—HTR2A—brain—attention deficit hyperactivity disorder	0.000256	0.00509	CbGeAlD
Minaprine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000233	0.00463	CbGeAlD
Minaprine—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	4.93e-05	0.000361	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.91e-05	0.00036	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	4.9e-05	0.000359	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.81e-05	0.000352	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	4.77e-05	0.00035	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	4.69e-05	0.000344	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	4.67e-05	0.000342	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	4.67e-05	0.000342	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	4.66e-05	0.000341	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.65e-05	0.000341	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.63e-05	0.000339	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.62e-05	0.000339	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	4.6e-05	0.000337	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	4.58e-05	0.000336	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	4.57e-05	0.000335	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	4.56e-05	0.000334	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.55e-05	0.000333	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.51e-05	0.000331	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.44e-05	0.000325	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	4.43e-05	0.000325	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.41e-05	0.000324	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	4.38e-05	0.000321	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.38e-05	0.000321	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.36e-05	0.00032	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	4.36e-05	0.00032	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.35e-05	0.000319	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	4.34e-05	0.000318	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.33e-05	0.000318	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.33e-05	0.000317	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.32e-05	0.000317	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.31e-05	0.000316	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.3e-05	0.000316	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.29e-05	0.000314	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	4.28e-05	0.000314	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.28e-05	0.000314	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.26e-05	0.000312	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.25e-05	0.000312	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.24e-05	0.000311	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.24e-05	0.000311	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	4.19e-05	0.000308	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.18e-05	0.000307	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.17e-05	0.000306	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.15e-05	0.000304	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.13e-05	0.000303	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.1e-05	0.0003	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.01e-05	0.000294	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.01e-05	0.000294	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	3.99e-05	0.000293	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.97e-05	0.000291	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.94e-05	0.000289	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.89e-05	0.000286	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.81e-05	0.00028	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.78e-05	0.000277	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.75e-05	0.000275	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.75e-05	0.000275	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.75e-05	0.000275	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.75e-05	0.000275	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.73e-05	0.000274	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.7e-05	0.000271	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.67e-05	0.000269	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.67e-05	0.000269	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.61e-05	0.000265	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.59e-05	0.000263	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.58e-05	0.000262	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.52e-05	0.000258	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.52e-05	0.000258	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.47e-05	0.000255	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.45e-05	0.000253	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	3.41e-05	0.00025	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.4e-05	0.00025	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.39e-05	0.000248	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.37e-05	0.000247	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.37e-05	0.000247	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.36e-05	0.000246	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.33e-05	0.000244	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.32e-05	0.000243	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.32e-05	0.000243	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.28e-05	0.00024	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.25e-05	0.000239	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.25e-05	0.000238	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.24e-05	0.000237	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.24e-05	0.000237	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.24e-05	0.000237	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.21e-05	0.000235	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.19e-05	0.000234	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.19e-05	0.000234	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.17e-05	0.000232	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.15e-05	0.000231	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.06e-05	0.000225	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.05e-05	0.000224	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.01e-05	0.000221	CbGpPWpGaD
Minaprine—ACHE—Metabolism—TPH2—attention deficit hyperactivity disorder	3e-05	0.00022	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	3e-05	0.00022	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.98e-05	0.000219	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.98e-05	0.000218	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.98e-05	0.000218	CbGpPWpGaD
Minaprine—ACHE—Metabolism—DPYD—attention deficit hyperactivity disorder	2.95e-05	0.000217	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.94e-05	0.000216	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.94e-05	0.000215	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.93e-05	0.000215	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.91e-05	0.000214	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.91e-05	0.000213	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.9e-05	0.000212	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.89e-05	0.000212	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.89e-05	0.000212	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.88e-05	0.000211	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.86e-05	0.000209	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.84e-05	0.000208	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.84e-05	0.000208	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	2.83e-05	0.000208	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.83e-05	0.000207	CbGpPWpGaD
Minaprine—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	2.83e-05	0.000207	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.83e-05	0.000207	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.8e-05	0.000205	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.8e-05	0.000205	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.78e-05	0.000204	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.78e-05	0.000204	CbGpPWpGaD
Minaprine—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	2.78e-05	0.000204	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.77e-05	0.000203	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	2.77e-05	0.000203	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.77e-05	0.000203	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.75e-05	0.000201	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.71e-05	0.000198	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.63e-05	0.000193	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.62e-05	0.000192	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.61e-05	0.000191	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.59e-05	0.00019	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.59e-05	0.00019	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.58e-05	0.000189	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.57e-05	0.000189	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.57e-05	0.000188	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.56e-05	0.000188	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.55e-05	0.000187	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.55e-05	0.000187	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.53e-05	0.000185	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.52e-05	0.000185	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.52e-05	0.000184	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.51e-05	0.000184	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.51e-05	0.000184	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.5e-05	0.000184	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.5e-05	0.000184	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.49e-05	0.000183	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.47e-05	0.000181	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.47e-05	0.000181	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.46e-05	0.000181	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.46e-05	0.00018	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.45e-05	0.00018	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.45e-05	0.00018	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.44e-05	0.000179	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.43e-05	0.000178	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.42e-05	0.000177	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.42e-05	0.000177	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.4e-05	0.000176	CbGpPWpGaD
Minaprine—ACHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.4e-05	0.000176	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.39e-05	0.000175	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.37e-05	0.000174	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.35e-05	0.000172	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.34e-05	0.000171	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.31e-05	0.00017	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.3e-05	0.000169	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.29e-05	0.000168	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.28e-05	0.000167	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.27e-05	0.000167	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.27e-05	0.000166	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.27e-05	0.000166	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.26e-05	0.000166	CbGpPWpGaD
Minaprine—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.26e-05	0.000166	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.26e-05	0.000165	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.25e-05	0.000165	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.24e-05	0.000164	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.23e-05	0.000163	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.21e-05	0.000162	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.2e-05	0.000161	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.15e-05	0.000158	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.14e-05	0.000157	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.13e-05	0.000156	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.06e-05	0.000151	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.06e-05	0.000151	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.05e-05	0.00015	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.01e-05	0.000147	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.98e-05	0.000145	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.97e-05	0.000144	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.94e-05	0.000142	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.92e-05	0.000141	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.89e-05	0.000138	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.86e-05	0.000137	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.83e-05	0.000134	CbGpPWpGaD
Minaprine—ACHE—Metabolism—COMT—attention deficit hyperactivity disorder	1.82e-05	0.000133	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.81e-05	0.000133	CbGpPWpGaD
Minaprine—ACHE—Metabolism—MAOA—attention deficit hyperactivity disorder	1.81e-05	0.000132	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.78e-05	0.000131	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.78e-05	0.00013	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.76e-05	0.000129	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.75e-05	0.000128	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.74e-05	0.000127	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.74e-05	0.000127	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.72e-05	0.000126	CbGpPWpGaD
Minaprine—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	1.71e-05	0.000126	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.71e-05	0.000125	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.7e-05	0.000125	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.66e-05	0.000122	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.00012	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.61e-05	0.000118	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.6e-05	0.000117	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.58e-05	0.000116	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.55e-05	0.000114	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.52e-05	0.000112	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.52e-05	0.000111	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.5e-05	0.00011	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.49e-05	0.00011	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.49e-05	0.000109	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.47e-05	0.000107	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.43e-05	0.000105	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.41e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.4e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.39e-05	0.000102	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.38e-05	0.000101	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.37e-05	0.0001	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.34e-05	9.86e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.34e-05	9.85e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.34e-05	9.81e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.33e-05	9.73e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.32e-05	9.69e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	9.64e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.31e-05	9.57e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.3e-05	9.52e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.23e-05	9.03e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.23e-05	9.03e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.22e-05	8.92e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.22e-05	8.92e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.21e-05	8.88e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.21e-05	8.87e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.15e-05	8.41e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.13e-05	8.26e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.85e-06	7.22e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.81e-06	7.19e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.37e-06	6.87e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.66e-06	6.35e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.47e-06	6.21e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—EP300—attention deficit hyperactivity disorder	7.8e-06	5.72e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	7.46e-06	5.47e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.41e-06	5.43e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	7.35e-06	5.39e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.44e-06	4.72e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.08e-06	4.45e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.2e-06	3.81e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.59e-06	3.36e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.51e-06	3.31e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.49e-06	3.29e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.2e-06	2.35e-05	CbGpPWpGaD
